Ulrich Mack
- Massive monoclonal expansion of CD4 T-cells specific for a Mycobacterium tuberculosis ESAT-6 peptideBy Tobias Hodapp, Urban Sester, Ulrich Mack, Mahavir Singh, Thomas Meier, Elisabeth Wiech, Paul Fisch, Stephan Ehl and Martina SesterTobias HodappUrban SesterUlrich MackMahavir SinghThomas MeierElisabeth WiechPaul FischStephan EhlMartina Sester
- Role of basophils in immunological memory responses to pneumococcal protein antigens and S. pneumoniae infections in miceBy Andrea Bischof, Christina Brumshagen, Regina Maus, Matthias Mack, Susan Hollingshead, David Briles, Tobias Welte and Ulrich MausAndrea Bischof1Department of Experimental Pneumology, Hannover Medical School, Hannover, GermanyChristina Brumshagen1Department of Experimental Pneumology, Hannover Medical School, Hannover, GermanyRegina Maus1Department of Experimental Pneumology, Hannover Medical School, Hannover, GermanyMatthias Mack2Department of Internal Medicine II, University Hospital, Regensburg, GermanySusan Hollingshead3Department of Microbiology, University of Alabama at Birmingham, United StatesDavid Briles3Department of Microbiology, University of Alabama at Birmingham, United StatesTobias Welte4Clinic for Pneumology, Hannover Medical School, Hannover, GermanyUlrich Maus1Department of Experimental Pneumology, Hannover Medical School, Hannover, Germany
- CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumabBy Ganesh Raghu, Fernando J. Martinez, Kevin K. Brown, Ulrich Costabel, Vincent Cottin, Athol U. Wells, Lisa Lancaster, Kevin F. Gibson, Tarik Haddad, Prasheen Agarwal, Michael Mack, Bidisha Dasgupta, Ivo P. Nnane, Susan K. Flavin and Elliot S. BarnathanArticle | Published in 2015 in European Respiratory JournalGanesh Raghu1Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, WA, USAFernando J. Martinez2Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USAKevin K. Brown3Department of Medicine, National Jewish Health, Denver, CO, USAUlrich Costabel4Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, GermanyVincent Cottin5National Reference Centre, Department of Respiratory Medicine, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Lyon, FranceAthol U. Wells6Royal Brompton Hospital, Imperial College London NHS Healthcare Trust, London, UKLisa Lancaster7Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN, USAKevin F. Gibson8Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USATarik Haddad9New Lung Associates, Tampa, FL, USAPrasheen Agarwal10Janssen Research & Development LLC, Spring House, PA, USAMichael Mack10Janssen Research & Development LLC, Spring House, PA, USABidisha Dasgupta10Janssen Research & Development LLC, Spring House, PA, USAIvo P. Nnane10Janssen Research & Development LLC, Spring House, PA, USASusan K. Flavin10Janssen Research & Development LLC, Spring House, PA, USAElliot S. Barnathan10Janssen Research & Development LLC, Spring House, PA, USA
- CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumabBy Ganesh Raghu, Fernando J. Martinez, Kevin K. Brown, Ulrich Costabel, Vincent Cottin, Athol U. Wells, Lisa Lancaster, Kevin F. Gibson, Tarik Haddad, Prasheen Agarwal, Michael Mack, Bidisha Dasgupta, Ivo P. Nnane, Susan K. Flavin and Elliot S. BarnathanGanesh Raghu1Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, WA, USAFernando J. Martinez2Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USAKevin K. Brown3Department of Medicine, National Jewish Health, Denver, CO, USAUlrich Costabel4Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, GermanyVincent Cottin5National Reference Centre, Department of Respiratory Medicine, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Lyon, FranceAthol U. Wells6Royal Brompton Hospital, Imperial College London NHS Healthcare Trust, London, UKLisa Lancaster7Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN, USAKevin F. Gibson8Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USATarik Haddad9New Lung Associates, Tampa, FL, USAPrasheen Agarwal10Janssen Research & Development LLC, Spring House, PA, USAMichael Mack10Janssen Research & Development LLC, Spring House, PA, USABidisha Dasgupta10Janssen Research & Development LLC, Spring House, PA, USAIvo P. Nnane10Janssen Research & Development LLC, Spring House, PA, USASusan K. Flavin10Janssen Research & Development LLC, Spring House, PA, USAElliot S. Barnathan10Janssen Research & Development LLC, Spring House, PA, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
